Future treatment options for human African trypanosomiasis.

Amy J Jones1, Vicky M Avery1

  • 1a Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Brisbane, 4111, Australia.

Summary

Human African trypanosomiasis (HAT) cases have decreased by over 90%. Continued research for new treatments is crucial to prevent resurgence and achieve HAT elimination goals.